HOME >> MEDICINE >> NEWS
First step in developing heart hormone-based pill to control high blood pressure

NEW ORLEANS -- In an era of increasing death and illness from heart and blood vessel disease -- which also can impair kidney function -- Mayo Clinic researchers have designed two promising new cardiovascular treatment approaches. In the process, they have overcome a key technological hurdle that has stymied researchers around the world in the development of new therapies based on clusters of amino acids called peptides. The Mayo Clinic researchers will present their findings March 27 at the American College of Cardiologys 56th Annual Scientific Sessions.

Significance of the Mayo Clinic Research

The first advance supports the feasibility of developing a peptide-based drug that can be given in pill form to lower high blood pressure, and that is based on a hormone originating in the heart, called B-type natriuretic peptide (BNP).

"Our formulation of an oral peptide is a technological accomplishment that really can advance the field," says John Burnett, Jr., M.D., director of Mayo Clinics Cardiorenal Research Lab who led both studies. "Prior to this, it was unheard of that a peptide could be given orally, because it is so rapidly degraded by stomach enzymes. Yet we overcame this significant constraint. This is the first report demonstrating that a peptide -- in this case, BNP -- can be developed by innovative technology to be absorbed orally."

The second advance is the development of a therapeutic hybrid molecule that helps improve both heart and kidney function. Addressing kidney blood vessel disease in addition to heart vessel disease is an increasingly important clinical focus for therapies as kidney failure becomes epidemic in the 21st century, and diseases of both heart and kidney link the health of the two organ systems.

Heart Hormone Pill for High Blood Pressure

Heart disease continues to be a leading cause of death and disability in Western countries, and kidney disease is a fast-gro
'"/>

Contact: Traci Klein
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
27-Mar-2007


Page: 1 2 3

Related medicine news :

1. First of its kind report on how children with brain tumors perform at school
2. First clinical trial of gene therapy for childhood blindness
3. First nationwide child health and air pollution study commences
4. First greenhouse gas animations produced using Envisat SCIAMACHY data
5. First ozone and nitrogen dioxide measurements from MetOp-A
6. First-degree fetal heart block may be reversible
7. 10 outstanding scientists chosen as First Environmental Health Science Fellows
8. First-time mothers at increased risk for postpartum mental disorders
9. Transforming knowledge into economic benefits -- EPSRCs First Knowledge Transfer Challenge Awards
10. First Quantum Grant to fund stem cell repair of damage from stroke
11. First major study of mammalian disorderly proteins

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology:
Cached News: